ARCC logo

ARCC · Ares Capital Corporation

Last updated Jul 09, 2026
Recommendation
HOLD
12-Month Target
—
Reference Price
—
Jul 09, 2026
L2 Capital Institutional Verdict

Ares Capital Corporation (ARCC) is currently rated HOLD with no fixed 12-month price target. Based on forensic analysis of SEC filings and audited cash flows, Moderate conviction reflects Ares Capital Corporation (ARCC) is rated HOLD with no 12-month target or implied return due to valuation tensions between its attractive....

Executive Thesis

Ares Capital Corporation (ARCC) is rated HOLD with no 12-month target or implied return due to valuation tensions between its attractive dividend yield and recent NAV compression driven by spread widening. The company’s core moat lies in its large, well-diversified BDC portfolio generating stable high single-digit yields supported by 67 consecutive quarters of dividend stability. However, non-cash mark-to-market loan markdowns have pressured GAAP earnings, and while dividend coverage remains solid, ongoing spread volatility and modest leverage warrant caution. We recommend a neutral stance, suggesting investors monitor credit conditions closely before considering incremental exposure.

Frequently Asked Questions: ARCC

What is L2 Capital's investment rating and price target for ARCC?

L2 Capital currently maintains an institutional rating of HOLD on Ares Capital Corporation (ARCC) with no fixed 12-month price target, backed by Moderate conviction.

What is the core investment thesis for ARCC?

Ares Capital Corporation (ARCC) is rated HOLD with no 12-month target or implied return due to valuation tensions between its attractive dividend yield and recent NAV compression driven by spread widening. The company’s core moat lies in its large, well-diversified BDC portfolio generating stable high single-digit yields supported by 67 consecutive quarters of dividend stability. However, non-cash mark-to-market loan markdowns have pressured GAAP earnings, and while dividend coverage remains solid, ongoing spread volatility and modest leverage warrant caution. We recommend a neutral stance, suggesting investors monitor credit conditions closely before considering incremental exposure.